Discovery On Target 2022
17
Oct
-
20
Oct
2022
When
Boston
Massachusetts
USA
Where

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules. We aim to meet your research needs.

Similar Events

You May Like

Event

Cambridge Healthtech Institute

0/5
(0)

Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.

17 - 20 Oct 2022
Hybrid

Speakers and Delegates
Industry Experts and Thought Leaders

Adjunct Lecturer - Immuno-Oncology
Scientific Associate Director
Vice President of Biology
EVP, Head of Drug Discovery
Co-founder & CEO
Associate Director, Immuno-Oncology
Chief Medical Officer
Scientific Director

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Charles River Laboratories

At Charles River, we are passionate about our role in improving the quality of people’s lives.

Reaction Biology

Reaction Biology provides pre-clinical drug discovery solutions as your trusted partner.

WuXi AppTec

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients.

Sai Life Sciences Ltd

Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow.

Fluidic Analytics

Fluidic Analytics – Understand the Machinery of Life.

Agilent Technologies

Analytical scientists and clinical researchers worldwide rely on Agilent to help fulfill their most complex laboratory demands.

Twist Bioscience

Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA.

Oncodesign

Founded in 1995 by Dr Philippe Genne, the Company’s CEO and Chairman, Oncodesign is a biopharma company dedicated to the precision medicine.

Collaborative Drug Discovery - CDD VAULT

Collaborative Drug Discovery's CDD VAULT is a hosted biological and chemical database that securely manages your private and external data.

BPS Bioscience Inc.

BPS manufactures one of the largest selections of recombinant enzymes, neutralizing antibodies, inhibitor assay kits, lentiviruses and cell lines for drug discovery and continues to expand its drug discovery products.

Horizon Discovery

Horizon Discovery, a PerkinElmer company, drives the application of gene editing and gene modulation to enable world-leading academic institutes, pharmaceutical and biotechnology companies, as well as clinical diagnostic laboratories, to identify the

Curi Bio

Curi Bio is accelerating the discovery of the next generation of medicines by integrating human cells, systems, and data.

Altis Biosystems

Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research. The product is called RepliGut.

Biosensing Instrument Inc

Biosensing Instrument is a life science company that designs and supplies award winning label-free molecular interaction instruments based on the Surface Plasmon Resonance technology.

Carterra

Carterra is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates.

Cellecta, Inc.

Cellecta provides HT loss-of-function genetic screening services for the discovery and functional characterization of novel therapeutic targets.

Domainex

Domainex is a fully integrated drug discovery service company based near Cambridge, UK serving pharmaceutical, biotechnology, academic and patient foundations globally.

Integral Molecular

Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies for under-exploited membrane protein targets, including GPCRs, ion channels, and transporters.

ION Biosciences

We are committed to providing pure, high-quality indicators to empower better research results for basic and translational research. Our vision is to create new and innovative discovery tools for scientists across all fields of cell research.

LAXAI Life Sciences

Our goal is to produce fast and innovative solutions to global pharmaceutical and specialty chemical companies within the space of contract research, development and manufacturing.

Multispan, Inc.

Multispan, Inc. is a premier assay screening technology provider targeting GPCRs, kinases and beyond using endogenously expressed targets in primary cells and recombinant stable cell lines.

Organizer

Get emails from us

Thank you
Oops! Something went wrong